A histopathological scoring and grading system to predict outcome for patients with AA amyloidosis
Purpose Renal involvement is associated with significant morbidity and mortality in AA amyloidosis. Extend of amyloid deposition in kidney biopsies may be predictive for clinical manifestations and outcomes. The aim of our study is to assess clinical features of patients with biopsy-proven renal AA...
Gespeichert in:
Veröffentlicht in: | International urology and nephrology 2020-07, Vol.52 (7), p.1297-1304 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1304 |
---|---|
container_issue | 7 |
container_start_page | 1297 |
container_title | International urology and nephrology |
container_volume | 52 |
creator | Celtik, Aygul Sen, Sait Keklik, Fatma Saydam, Guray Asci, Gulay Sarsik, Banu Ozkahya, Mehmet Toz, Huseyin |
description | Purpose
Renal involvement is associated with significant morbidity and mortality in AA amyloidosis. Extend of amyloid deposition in kidney biopsies may be predictive for clinical manifestations and outcomes. The aim of our study is to assess clinical features of patients with biopsy-proven renal AA amyloidosis and to evaluate the relationship between histopathological scoring and grading of renal amyloid deposition with clinical findings and outcomes.
Methods
The study included 86 patients who were diagnosed with renal AA amyloidosis. The demographic and clinical features at the time of biopsy and follow-up data were retrospectively collected. Amyloid deposition in glomeruli, interstitium, vessels and tubulointerstitial findings were scored and renal amyloid prognostic score (RAPS) was assigned by adding all scores. RAPS was further divided into three grades (RAPS grade I, II, III).
Results
Median age was 50 (36–59) years. Familial Mediterranean fever was the leading cause. RAPS grade and interstitial inflammatory infiltration were associated with baseline eGFR and glomerular amyloid deposition was associated with proteinuria. During the follow-up period (median 50 months), 39 patients developed ESRD. Extensive (involving > 50%) glomerular amyloid deposition, baseline eGFR and proteinuria were independent risk factors for progression to end stage renal disease. Death censored renal survival was significantly lower among patients with RAPS grade III compared to those with RAPS grade I and II. Patient survival rate was not different according to RAPS grade.
Conclusions
Degree of renal amyloid accumulation is associated with renal function and outcome. The scoring and grading system may be predictive in clinical outcome and contribute to understanding of disease mechanism. |
doi_str_mv | 10.1007/s11255-020-02505-y |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2412990660</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2416729002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-5b663b2d6d6d2b9d802fa036e5487629891aad1c0a60889afc4ac9171fac21ef3</originalsourceid><addsrcrecordid>eNp9kUFr3DAQhUVpaTZp_0APRdBLL25H0kq2jktom0Cgl_YsZFneVbAtRyMT_O-j7aYJ5BCEkA7fezO8R8gnBt8YQP0dGeNSVsChXAmyWt-QDZO1qLhstm_JBgSwiikuzsg54i0A6AbgPTkTXHItGr4h7Y4eAuY423yIQ9wHZweKLqYw7amdOrpPtjv-ccXsR5ojnZPvgss0LtnF0dM-JlrkwU8Z6X3IB7rbUTuuQwxdxIAfyLveDug_Pr4X5O_PH38ur6qb37-uL3c3lRO1zJVslRIt71Q5vNVdA7y3IJSX26ZWXDeaWdsxB1ZB02jbu611mtWst44z34sL8vXkO6d4t3jMZgzo_DDYyccFDd8yrjUoBQX98gK9jUuaynZHStVcA_BC8RPlUkRMvjdzCqNNq2Fgjg2YUwOmNGD-NWDWIvr8aL20o--eJP8jL4A4ATgfQ_bpefYrtg8BgpIM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2416729002</pqid></control><display><type>article</type><title>A histopathological scoring and grading system to predict outcome for patients with AA amyloidosis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Celtik, Aygul ; Sen, Sait ; Keklik, Fatma ; Saydam, Guray ; Asci, Gulay ; Sarsik, Banu ; Ozkahya, Mehmet ; Toz, Huseyin</creator><creatorcontrib>Celtik, Aygul ; Sen, Sait ; Keklik, Fatma ; Saydam, Guray ; Asci, Gulay ; Sarsik, Banu ; Ozkahya, Mehmet ; Toz, Huseyin</creatorcontrib><description>Purpose
Renal involvement is associated with significant morbidity and mortality in AA amyloidosis. Extend of amyloid deposition in kidney biopsies may be predictive for clinical manifestations and outcomes. The aim of our study is to assess clinical features of patients with biopsy-proven renal AA amyloidosis and to evaluate the relationship between histopathological scoring and grading of renal amyloid deposition with clinical findings and outcomes.
Methods
The study included 86 patients who were diagnosed with renal AA amyloidosis. The demographic and clinical features at the time of biopsy and follow-up data were retrospectively collected. Amyloid deposition in glomeruli, interstitium, vessels and tubulointerstitial findings were scored and renal amyloid prognostic score (RAPS) was assigned by adding all scores. RAPS was further divided into three grades (RAPS grade I, II, III).
Results
Median age was 50 (36–59) years. Familial Mediterranean fever was the leading cause. RAPS grade and interstitial inflammatory infiltration were associated with baseline eGFR and glomerular amyloid deposition was associated with proteinuria. During the follow-up period (median 50 months), 39 patients developed ESRD. Extensive (involving > 50%) glomerular amyloid deposition, baseline eGFR and proteinuria were independent risk factors for progression to end stage renal disease. Death censored renal survival was significantly lower among patients with RAPS grade III compared to those with RAPS grade I and II. Patient survival rate was not different according to RAPS grade.
Conclusions
Degree of renal amyloid accumulation is associated with renal function and outcome. The scoring and grading system may be predictive in clinical outcome and contribute to understanding of disease mechanism.</description><identifier>ISSN: 0301-1623</identifier><identifier>EISSN: 1573-2584</identifier><identifier>DOI: 10.1007/s11255-020-02505-y</identifier><identifier>PMID: 32529382</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Adult ; Amyloidosis ; Amyloidosis - pathology ; Biopsy ; Epidermal growth factor receptors ; Familial Mediterranean fever ; Female ; Humans ; Inflammation ; Kidney Diseases - pathology ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Morbidity ; Nephrology ; Nephrology - Original Paper ; Predictive Value of Tests ; Prognosis ; Proteinuria ; Renal function ; Retrospective Studies ; Risk factors ; Survival ; Urology</subject><ispartof>International urology and nephrology, 2020-07, Vol.52 (7), p.1297-1304</ispartof><rights>Springer Nature B.V. 2020</rights><rights>Springer Nature B.V. 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-5b663b2d6d6d2b9d802fa036e5487629891aad1c0a60889afc4ac9171fac21ef3</citedby><cites>FETCH-LOGICAL-c375t-5b663b2d6d6d2b9d802fa036e5487629891aad1c0a60889afc4ac9171fac21ef3</cites><orcidid>0000-0003-4399-3746</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11255-020-02505-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11255-020-02505-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32529382$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Celtik, Aygul</creatorcontrib><creatorcontrib>Sen, Sait</creatorcontrib><creatorcontrib>Keklik, Fatma</creatorcontrib><creatorcontrib>Saydam, Guray</creatorcontrib><creatorcontrib>Asci, Gulay</creatorcontrib><creatorcontrib>Sarsik, Banu</creatorcontrib><creatorcontrib>Ozkahya, Mehmet</creatorcontrib><creatorcontrib>Toz, Huseyin</creatorcontrib><title>A histopathological scoring and grading system to predict outcome for patients with AA amyloidosis</title><title>International urology and nephrology</title><addtitle>Int Urol Nephrol</addtitle><addtitle>Int Urol Nephrol</addtitle><description>Purpose
Renal involvement is associated with significant morbidity and mortality in AA amyloidosis. Extend of amyloid deposition in kidney biopsies may be predictive for clinical manifestations and outcomes. The aim of our study is to assess clinical features of patients with biopsy-proven renal AA amyloidosis and to evaluate the relationship between histopathological scoring and grading of renal amyloid deposition with clinical findings and outcomes.
Methods
The study included 86 patients who were diagnosed with renal AA amyloidosis. The demographic and clinical features at the time of biopsy and follow-up data were retrospectively collected. Amyloid deposition in glomeruli, interstitium, vessels and tubulointerstitial findings were scored and renal amyloid prognostic score (RAPS) was assigned by adding all scores. RAPS was further divided into three grades (RAPS grade I, II, III).
Results
Median age was 50 (36–59) years. Familial Mediterranean fever was the leading cause. RAPS grade and interstitial inflammatory infiltration were associated with baseline eGFR and glomerular amyloid deposition was associated with proteinuria. During the follow-up period (median 50 months), 39 patients developed ESRD. Extensive (involving > 50%) glomerular amyloid deposition, baseline eGFR and proteinuria were independent risk factors for progression to end stage renal disease. Death censored renal survival was significantly lower among patients with RAPS grade III compared to those with RAPS grade I and II. Patient survival rate was not different according to RAPS grade.
Conclusions
Degree of renal amyloid accumulation is associated with renal function and outcome. The scoring and grading system may be predictive in clinical outcome and contribute to understanding of disease mechanism.</description><subject>Adult</subject><subject>Amyloidosis</subject><subject>Amyloidosis - pathology</subject><subject>Biopsy</subject><subject>Epidermal growth factor receptors</subject><subject>Familial Mediterranean fever</subject><subject>Female</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Kidney Diseases - pathology</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Morbidity</subject><subject>Nephrology</subject><subject>Nephrology - Original Paper</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Proteinuria</subject><subject>Renal function</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Survival</subject><subject>Urology</subject><issn>0301-1623</issn><issn>1573-2584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUFr3DAQhUVpaTZp_0APRdBLL25H0kq2jktom0Cgl_YsZFneVbAtRyMT_O-j7aYJ5BCEkA7fezO8R8gnBt8YQP0dGeNSVsChXAmyWt-QDZO1qLhstm_JBgSwiikuzsg54i0A6AbgPTkTXHItGr4h7Y4eAuY423yIQ9wHZweKLqYw7amdOrpPtjv-ccXsR5ojnZPvgss0LtnF0dM-JlrkwU8Z6X3IB7rbUTuuQwxdxIAfyLveDug_Pr4X5O_PH38ur6qb37-uL3c3lRO1zJVslRIt71Q5vNVdA7y3IJSX26ZWXDeaWdsxB1ZB02jbu611mtWst44z34sL8vXkO6d4t3jMZgzo_DDYyccFDd8yrjUoBQX98gK9jUuaynZHStVcA_BC8RPlUkRMvjdzCqNNq2Fgjg2YUwOmNGD-NWDWIvr8aL20o--eJP8jL4A4ATgfQ_bpefYrtg8BgpIM</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Celtik, Aygul</creator><creator>Sen, Sait</creator><creator>Keklik, Fatma</creator><creator>Saydam, Guray</creator><creator>Asci, Gulay</creator><creator>Sarsik, Banu</creator><creator>Ozkahya, Mehmet</creator><creator>Toz, Huseyin</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4399-3746</orcidid></search><sort><creationdate>20200701</creationdate><title>A histopathological scoring and grading system to predict outcome for patients with AA amyloidosis</title><author>Celtik, Aygul ; Sen, Sait ; Keklik, Fatma ; Saydam, Guray ; Asci, Gulay ; Sarsik, Banu ; Ozkahya, Mehmet ; Toz, Huseyin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-5b663b2d6d6d2b9d802fa036e5487629891aad1c0a60889afc4ac9171fac21ef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Amyloidosis</topic><topic>Amyloidosis - pathology</topic><topic>Biopsy</topic><topic>Epidermal growth factor receptors</topic><topic>Familial Mediterranean fever</topic><topic>Female</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Kidney Diseases - pathology</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Morbidity</topic><topic>Nephrology</topic><topic>Nephrology - Original Paper</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Proteinuria</topic><topic>Renal function</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Survival</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Celtik, Aygul</creatorcontrib><creatorcontrib>Sen, Sait</creatorcontrib><creatorcontrib>Keklik, Fatma</creatorcontrib><creatorcontrib>Saydam, Guray</creatorcontrib><creatorcontrib>Asci, Gulay</creatorcontrib><creatorcontrib>Sarsik, Banu</creatorcontrib><creatorcontrib>Ozkahya, Mehmet</creatorcontrib><creatorcontrib>Toz, Huseyin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>International urology and nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Celtik, Aygul</au><au>Sen, Sait</au><au>Keklik, Fatma</au><au>Saydam, Guray</au><au>Asci, Gulay</au><au>Sarsik, Banu</au><au>Ozkahya, Mehmet</au><au>Toz, Huseyin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A histopathological scoring and grading system to predict outcome for patients with AA amyloidosis</atitle><jtitle>International urology and nephrology</jtitle><stitle>Int Urol Nephrol</stitle><addtitle>Int Urol Nephrol</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>52</volume><issue>7</issue><spage>1297</spage><epage>1304</epage><pages>1297-1304</pages><issn>0301-1623</issn><eissn>1573-2584</eissn><abstract>Purpose
Renal involvement is associated with significant morbidity and mortality in AA amyloidosis. Extend of amyloid deposition in kidney biopsies may be predictive for clinical manifestations and outcomes. The aim of our study is to assess clinical features of patients with biopsy-proven renal AA amyloidosis and to evaluate the relationship between histopathological scoring and grading of renal amyloid deposition with clinical findings and outcomes.
Methods
The study included 86 patients who were diagnosed with renal AA amyloidosis. The demographic and clinical features at the time of biopsy and follow-up data were retrospectively collected. Amyloid deposition in glomeruli, interstitium, vessels and tubulointerstitial findings were scored and renal amyloid prognostic score (RAPS) was assigned by adding all scores. RAPS was further divided into three grades (RAPS grade I, II, III).
Results
Median age was 50 (36–59) years. Familial Mediterranean fever was the leading cause. RAPS grade and interstitial inflammatory infiltration were associated with baseline eGFR and glomerular amyloid deposition was associated with proteinuria. During the follow-up period (median 50 months), 39 patients developed ESRD. Extensive (involving > 50%) glomerular amyloid deposition, baseline eGFR and proteinuria were independent risk factors for progression to end stage renal disease. Death censored renal survival was significantly lower among patients with RAPS grade III compared to those with RAPS grade I and II. Patient survival rate was not different according to RAPS grade.
Conclusions
Degree of renal amyloid accumulation is associated with renal function and outcome. The scoring and grading system may be predictive in clinical outcome and contribute to understanding of disease mechanism.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>32529382</pmid><doi>10.1007/s11255-020-02505-y</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4399-3746</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-1623 |
ispartof | International urology and nephrology, 2020-07, Vol.52 (7), p.1297-1304 |
issn | 0301-1623 1573-2584 |
language | eng |
recordid | cdi_proquest_miscellaneous_2412990660 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Adult Amyloidosis Amyloidosis - pathology Biopsy Epidermal growth factor receptors Familial Mediterranean fever Female Humans Inflammation Kidney Diseases - pathology Male Medicine Medicine & Public Health Middle Aged Morbidity Nephrology Nephrology - Original Paper Predictive Value of Tests Prognosis Proteinuria Renal function Retrospective Studies Risk factors Survival Urology |
title | A histopathological scoring and grading system to predict outcome for patients with AA amyloidosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A33%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20histopathological%20scoring%20and%20grading%20system%20to%20predict%20outcome%20for%20patients%20with%20AA%20amyloidosis&rft.jtitle=International%20urology%20and%20nephrology&rft.au=Celtik,%20Aygul&rft.date=2020-07-01&rft.volume=52&rft.issue=7&rft.spage=1297&rft.epage=1304&rft.pages=1297-1304&rft.issn=0301-1623&rft.eissn=1573-2584&rft_id=info:doi/10.1007/s11255-020-02505-y&rft_dat=%3Cproquest_cross%3E2416729002%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2416729002&rft_id=info:pmid/32529382&rfr_iscdi=true |